H emangiomas are proliferative lesions that are characterized by increased proliferation of vascular endothelial cells and are usually identified after birth. Mediastinal hemangioma is a rare entity that was first reported in 1914 by Shannon. [1] They comprise about 0.5% of all mediastinal tumors. [2] Preoperative diagnosis is difficult because, although there are characteristic findings in radiologic imaging studies, they are present in less than 20% of the cases. [3] Hemangiomas are predominantly seen in the anterior mediastinum. Fewer than 25 cases of posterior mediastinal hemangioma (PMH) have been reported in the English literature, none of which are from Turkey.
Case Report
A 50-year-old woman was referred to the thoracic surgery outpatient clinic with a complaint of intermittent shortness of breath that was present for at least 12 years and gradually increasing for about 1 year. The patient also had posterior chest pain that started 1 year ago and had been increasing in intensity since. The patient had been evaluated for dyspnea in another medical facility 7 months ago and a pleural effusion was detected on chest x-ray. Diagnostic thoracentesis was performed at the time, but cytology did not yield pathologic results. In our evaluation, physical examination was unremarkable except diminished breath sounds over the right hemithorax. Complete blood count and blood chemistry were within normal limits. In the chest x-ray, there was a right-sided pleural effusion filling two-thirds of the hemithorax. The patient was admitted for further evaluation and symptomatic relief. The pleural effusion was drained with a tube thoracostomy and samples of pleural fluid were obtained for repeat cytology and cultures. The results indicated exudative pleural effusion but failed to point to a malignant or infectious etiology. Following re-expansion of the lung, computed tomography (CT) of the chest was done, which revealed a mass in the paravertebral space with a size of 3x3 centimeters. The patient was scheduled for thoracotomy and total excision of the mass with a preoperative diagnosis of neurogenic tumor (neurofibroma) (Fig. 1) . During the operation, the mass was completely excised, but unusually high amount of bleeding from surrounding tissues required careful hemostasis with propylene monofilament sutures. On gross examination, the outer surface was covered with pleura, cut surface was off-white in color with irregular foci of hemorrhage. Tissue samples were stained with immunohistochemistry for CD31, CD34, S-100 and pancytokeratin, which confirmed a diagnosis of hemangioma (Fig. 2 ). There were no complications postoperatively during the hospital stay or in the first-year follow-up.
Discussion
Hemangiomas are benign tumors that can arise anywhere in the body. Mediastinal hemangiomas are predominantly seen in the anterior mediastinum. In the English literature, fewer than 25 cases of PMH have been reported (Table 1) . PMH can infiltrate neighboring tissues microscopically, however, it has limited potential for aggressive biological behavior.
75% of mediastinal hemangiomas are encountered before the age of 35, while 75% of PMH are encountered after the age of 35. Typically seen in adults, pediatric cases of the latter have also been reported. While there seems to be no gender preference in mediastinal hemangiomas, reported cases of PMH are usually female patients.
PMH cases are usually asymptomatic and lesions are identified incidentally on imaging studies. In symptomatic cases, symptoms vary according to tumor size and location and may include non-specific chest pain, cough, and dysphagia. In our case, the patient presented with recurrent pleural effusion and posterior chest pain.
Mediastinal hemangiomas are extremely difficult to diagnose preoperatively. Yamazaki et al. [4] reported a preoperative definitive diagnosis in only 2 out 61 cases of mediastinal hemangiomas in Japan. There are no reported cases of posterior mediastinal hemangiomas in the literature with a preoperative definitive diagnosis. In the chest CT, the lesion appears as a homogenous mass with lobulated margins, which is similar to a neurofibroma. Hemangiomas are identifiable by phleboliths, which look like circular calcifications within a mass, seen in the bone window of a chest CT. However, phleboliths are seen in less than 20% of the cases. [2] There are reports that demonstrate the efficacy of magnetic resonance imaging (MRI) in the diagnosis of mediastinal tumors. [5] Significantly high intensity on fat-suppressed T2-weighted images may be characteristic in MRI. [6] Our patient was operated with a preliminary diagnosis of neurofibroma, which is the most common tumor in the posterior mediastinum.
As chest CT and MRI are inadequate in the definitive diagnosis of PMH, histopathological confirmation is required. Percutaneous needle biopsies are not recommended due to the risk of bleeding. Though video-assisted thoracoscopic surgery (VATS) is gaining more and more widespread use, we believe surgical treatment with thoracotomy is safer and more appropriate for a VATS-inexperienced surgeon, because the risk of massive bleeding can be managed under controlled conditions with thoracotomy. Total excision is the recommended procedure, especially for cases without infiltration to neighboring structures, however, subtotal resections are acceptable in infiltrative tumors, since symptoms arise due to the mass effect of the tumor, and subside when the mass effect diminishes. Also, there are no reports of malignant transformation of mediastinal hemangiomas. [7] However, patients must be closely followed up, because local recurrence, though rare, is possible. [7] For patients with local recurrence, one treatment option is vascular embolization, but it should be noted that there is a risk of spinal infarct for PMH involving the lower thoracic vertebrae or extending into the spinal canal through intervertebral foramina. [8] In such cases, reoperation is recommended. The effect of radiotherapy on these cases is not well known. [9] In conclusion, PMH is an extremely rare benign tumor, although it may show local invasion. It is hard to diagnose Ridene et al. [2] 58 y F Incidental finding 5 Neurogenic tumor Thoracotomy complete excision Ridene et al. [2] 66 y M Paresthesia of upper 6 N/A Thoracotomy complete extremity excision Ridene et al. [2] 16 y N/A Asymptomatic 5 N/A Video assisted thoracic surgery, complete excision Zeyainan et al. [3] 65 y F Productive cough 5 Neurogenic Thoracotomy, complete tumor excision Yoshino et al. [6] 54 y F Asymptomatic 2.7 Suspicious to Thoracoscopic neurogenic tumor thoracotomy Hammoumi et al. [7] 63 M Dysphagia 6 Haematic liquid Thoracotomy, complete excision Maeda et al. [8] 67 y M Asymptomatic N/A Neurogenic Thoracotomy, complete tumor excision Yun et al. [9] 58 y F Back pain 6 N/A Thoracotomy, complete excision Moran et al. [10] 1 m F Rectal bleeding + N/A Hemangioma Autopsy finding facial telangiectasia Moran et al. [10] 48 y F Cough 3 N/A Thoracotomy complete excision Moran et al. [10] 37 y M Asymptomatic 9 N/A Thoracotomy complete excision Moran et al. [10] 35 y F Neck pain 7 N/A Thoracotomy complete excision Herman et al. [11] 7 m F Work up for N/A Neuroblastoma Only biopsy coronary heart disease Herman et al. [11] 8 w N/A Cyanosis, apnea N/A N/A Thoracotomy, partial resection, alfa interferon, short course steroid Taori et al. [12] 25 y M Back pain 9 N/A Thoracotomy, complete excision Sabharwal et al. [13] 4 m F Work up for tetralogy 2 Suspicious to Thoracotomy, complete of Fallot neuroblastoma excision Sabharwal et al. [13] 6 m F Work up for congestive Multiple Suspicious to Thoracotomy complete heart failure neuroblastoma excision Ampollini et al. [14] 71 F Asymptomatic 5 N/A Video assisted thoracic surgery Karamalou et al. [15] 57 y F Epigastric pain dyspnea 12.8 N/A Thoracotomy, complete excision Kubokura et al. [16] 58 y M Dyspnea, dysphagia, 8 N/A Thoracotomy, cystectomy back pain Seki et al. [17] 69 y F Asymptomatic 3.2 Neurogenic video-assisted thoracic tumor surgery Das et al. [18] 56 y F Chest pain 6 N/A Thoracotomy, complete excision with a chest CT or MRI; thus the diagnosis is usually made during surgery. For locally infiltrated lesions, subtotal resection of the tumor is acceptable in managing the risk of massive intraoperative bleeding.
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